Aigen Investment Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Aigen Investment Management’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-5,171	Closed	-$207K	–	709
2024 Q2	$207K	Buy	+5,171	New	+$214K	0.04%	616
2023 Q3	–	Sell	-8,868	Closed	-$510K	–	807
2023 Q2	$510K	Buy	8,868 +1,069	+14%	+$47.4K	0.08%	344
2023 Q1	$292K	Buy	+7,799	New	+$256K	0.04%	433
2021 Q3	–	Sell	-12,390	Closed	-$250K	–	462
2021 Q2	$250K	Sell	12,390 -3,687	-23%	-$69.5K	0.04%	359
2021 Q1	$295K	Sell	16,077 -5,195	-24%	-$96.6K	0.04%	416
2020 Q4	$428K	Sell	21,272 -2,628	-11%	-$51.1K	0.06%	434
2020 Q3	$448K	Buy	+23,900	New	+$481K	0.06%	429
2020 Q2	–	Sell	-3,134	Closed	-$47K	–	802
2020 Q1	$47K	Buy	3,134 +1,863	+147%	+$32.4K	0.01%	1002
2019 Q4	$25K	Buy	+1,271	New	+$24.4K	﹤0.01%	890

Other funds holding AMPH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Aigen Investment Management's AMPH Position: Q3 2024 in Review

Aigen Investment Management sold out of Amphastar Pharmaceuticals (AMPH) in Q3 2024, closing a stake of 5,171 shares — an estimated $207K sold.

Aigen Investment Management first reported a position in AMPH in Q4 2019 and held it in 9 quarters. The position peaked at $510K in Q2 2023. 279 funds tracked by Wall St. Rank hold AMPH as of Q3 2024.

Aigen Investment Management reported no remaining Amphastar Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
Aigen Investment Management sold 5,171 Amphastar Pharmaceuticals shares in Q3 2024, an estimated $207K.
Aigen Investment Management first reported a position in Amphastar Pharmaceuticals in Q4 2019 and held it in 9 quarters.
Aigen Investment Management's Amphastar Pharmaceuticals position peaked at $510K in Q2 2023.
279 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2024.

Based on Aigen Investment Management's 13F filing for Q3 2024, filed 5 Nov 2024.